Tagged with GAC

Neil McMaster – General Manager Contract Logistics, GAC Dubai

UAE Neil McMaster – General Manager Contract Logistics, GAC Dubai

UAE Neil McMaster, GAC Dubai’s General Manager Contract Logistics, discusses the key investments his company has made to stand out as the region’s go-to healthcare and pharmaceutical logistics provider, offering added-value services and high-quality customer standards. He also introduces GAC Dubai’s new high-tech building facility, reveals the key trends and challenges…

Switzerland: Fresh Tactics in the War on Cancer

Switzerland Switzerland: Fresh Tactics in the War on Cancer

Switzerland With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular conditions in terms of prevalence, Switzerland has long positioned itself firmly at the vanguard of countering a disease which the World Health Organization (WHO) predicts will reach an incidence rate of 22 million new…

Legacy Healthcare: Countering A Silent Pandemic

Switzerland Legacy Healthcare: Countering A Silent Pandemic

Switzerland Worldwide, severe side effects from classic medicine are becoming a health risk in themselves, often misdiagnosed as symptoms of other problems, resulting in further prescriptions, further side effects and unanticipated drug interactions; the so-called ‘prescription cascade’. Saad Harti, founder and CEO of botanical biopharma company Legacy Healthcare, describes this situation as “a…

Saad Harti – President, Legacy Healthcare, Switzerland

Switzerland Saad Harti – President, Legacy Healthcare, Switzerland

Switzerland Saad Harti, president of Legacy Healthcare, discusses the company’s origins, their unique focus on side-effect free botanical drugs for chronic conditions, and the importance of stakeholder education in this exciting but still immature field. Most of our current emphasis is on alleviating side effects of cancer treatments, also called…

Interview: Marco Cid – Director General, Investigacion Biomedica, Mexico

Mexico Interview: Marco Cid – Director General, Investigacion Biomedica, Mexico

Mexico Marco Cid, Director General of Investigacion Biomedica, shares how he successfully launched an innovative clinical research center (CRC) despite a challenging regulatory environment. He speaks about the inspiration behind his business model, the necessity of building a strong rapport with authoritative entities in the market, as well as fostering a…

PharmaLegacy Interview with Darren Ji, CEO, PharmaLegacy

PharmaLegacy Could you give us some personal background and tell us why you choose to come to the CRO side after a successful career at a multinational? A lot of people ask why I chose to make this transition after being at a pretty good position at Procter & Gamble, with…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page